Search
for
Sort by
Research 91–120 of 1000+
- Synaptic Long-Term Potentiation and Depression in the Rat Medial Vestibular Nuclei Depend on Neural Activation of Estrogenic and Androgenic Signals
- Why would men use finasteride in 2005?
- A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Sex hormones and related compounds, including hormonal contraceptives
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Clinical use of 5α-reductase inhibitors
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Geranylated Coumarins From Thai Medicinal Plant Mammea siamensis With Testosterone 5α-Reductase Inhibitory Activity
- Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
- The Modulation of Aromatase and Estrogen Receptor Alpha in Cultured Human Dermal Papilla Cells by Dexamethasone: A Novel Mechanism for Selective Action of Estrogen via Estrogen Receptor Beta?
- 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss
- Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
- Androgens and androgen receptor action in skin and hair follicles
- Adverse effects of common medications on male fertility